Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

155 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

MS-275 in Treating Patients With Hematologic Cancer

NCT00015925

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +43 more
Locations
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

NCT00077558

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +42 more
Locations
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
View Trial Details

Related conditions